MEX3B and non-small cell lung carcinoma: The results indicated that in NSCLC and LUAD, MEX3A, MEX3B, MEX3C, and MEX3D overexpression was significantly associated with a worse prognosis, and MEX3D overexpression was also associated with poor OS in LUSC.